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ABSTRACT:  The objective of this study as to determine the anti-atherogenic effect of cardipro-
a poly herbal cardiotonic which primarily contains the standardized extracts of Terminalia 
arjuna, Ocimum sanctum, Boerhaavia diffusa, Emblica officinalis and withania somnifera.  For 
this purpose, 24 adult wistar albino rats were equally divided into 4 groups.  Group I acted as 
control, Group 2 received individually cholesterol 100mg/kg dissolved in vegetable oil (4mg/ml) 
orally daily for 30 days.  Group 3 received cardiPro 25 mg/kg body weight individually orally 
dissolved in distilled water daily for 30 days in combination with cholesterol as in group2, wile 
group 4 instead received Cardipro @ 50mg/kg body weight along with cholesterol. It was found 
that plasma total lipid, cholesterol, low density lipids, very low density lipids, triglycerides as 
well as aortic cholesterol contents were higher in cholesterol fed rats in comparison to health 
controls.  Treatment with Cardipro significant; reduced the levels of these blood lipid profiles 
suggesting anti-atherogenic action of cardipro in rats. This was further strengthened b 
histopathological examination of Aorta in which the cholesterol fed rats treated with Cardipro 
@ 50% mg/kg body weight revealed only occasional presence of fat in the medial coat and intact 
elastic fibres in contrest to marked elevations and depressions I the tunica intima associated 
muscles of medical coat and disruption of elastic fibres in only cholesterol fed rats. 
 
INTRODUCTION : 
 
Atherosclerosi is intimately associated with 
various cardiovascular disturbances which 
have emerged as a major world health 
problem.  Atherosclerosis and associated 
heart diseases are not one of the principal 
causes of death in Western World and in al 
most every developing country (1). 
Extensive global research is continuing to 
develop pharmacological means for 
prevention and management of 
atherosclersis and allied cardiovascular 
problems.  Cardipro is a polyherbal 
cardiotonic formulation which contains the 
standardized extract of : Terminalia arjuna, 
Ocimum sanctum, Boerhaavia diffusa, 
Emblica officinalis and wtihania somnifera. 
 
Cardiopro is safe and non-toxic to 
experimental animals(2) Earlier studies have 
demonstrated that cardipro produced 
positive ionotropic and negative 
chronotrapic effect in addition to 
improvement n peripheral and coronary 
perfusion flow (3).  In clinical trials, patients 
of angina pectoris responded well when 
treated with cardipro (4,5). The constituents 
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of cardipro were reported to produce 
hypocholesterolaemic action (6-10). The 
present study was carried out to investigate 
the anti atherogenic action of Cardipro in 
experimental animals. 
 
MATERIALS & METHODS: 
 
The stud was conducted in adult wistar 
albino rats twenty four rats were equally 
divided into 4 groups referred as  
 
Group I (HC)    :   Healthy 
control. 
Group II (AC)   :   Cholesterol 
(100mg/kg) dissolved in hyfrogenated  
vegetable 
oil(4mg.ml) per 
animal, orally, daily, 
for 30 days. 
 
Group III (D-25)  :  Cardipro(25 
mg/kg) pre animal, orally, dissolved in  
distilled water, 
daily for 30 days in 
combination with  
cholesterols as 
stated for group II. 
 
Group (AD-50)  :  Same as group 
III but the dose of Cardipro was 50mg/kg pr  
animal. 
 
At the end of 30 days. Blood samples were 
collected from each rat and plasma was 
separated for the estimation of total lipid, 
total cholesterol, high density lipids (HDL), 
low density lipids (LDL), very low density 
lipids (VLDL) and triglyceride 
concentrations using diagonostic kit (Span 
diagnostics).  The animals were then 
sacrificed under overdoes of ether 
anaesthesia; the thoracic aorta of each rat 
was dissected out.  A portion of aorta was 
preserved informal-saline for histopathology 
and another portion for estimation of tissue 
cholesterol content. 
 
Statistical significance of data between 
groups in the present study was evaluated b 
employing student’s test.  A probability of 
less than 0.05 was considered significant. 
 
RESULTS 
 
Plasma total lipid, cholesterol, LDL, VLDL 
and triglyceride as well as aortic cholesterol 
contents were higher in cholesterol fed rats 
in comparison to healthy controls. Treatment 
with cardipro had reduced these blood lipid 
profiles in cholesterol fed rats (Table -1). 
 
Gross examination of aortic tissues of the 
cholesterol fed rats (AC) showed wrinkling 
of tunica intima with occasional ulceration 
and dis-colouration.  The arterial wall was 
moderately thickened in comparison the 
controls, Microscopically, There was 
gelatinous swelling and elevation and 
depressions (Fig I) of intima due to presence 
of structureless materials with karyorrhetic 
nuclei giving an appearance of microscopic 
mural thrombi and ulceration (Fig 3) with 
rough surface of tunica intima.  In medial 
coat, there was hypertrophy of smooth 
muscles which was rich in lipoid materials 
(Fig2) calcium salts were deposited as fine 
granular material in the intima in vonkossas 
stain.  In verhoeff’s stained sections, there 
was disruption of elastic fibres due to 
fragmentation and also presence of discrete 
fat vacuoles (Fig 4). 
 
In cardipro treated rats grossly the intima 
was less wrinkled and there was no evidence 
of microthrombi attached to the intimal 
surface and it was smooth.  There were only 
occasional are droplets in medial coat (Fig 
5) In verhoeff’s stained sections intact and 
continuous elastic fibres were noted (Fig 6) 
No deposition of calcium salts was noticed. 
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The thickness of medical coat was more or 
less akin those in healthy control.  
 
DISCUSSION 
 
An increased risk of atherosclersis is always 
associated with high blood concentrations of 
total lipid, LDL, VLDL, triglycerides and 
total cholesterol wit low concentration of 
HDL (11). As has been noticed in this stud, 
Significant reduction in blood concentration 
of cholesterol, total lipid, LDL, VLDL and 
triglycerides brought about b cardipro in 
cholesterol fed rats as compared to untreated 
cholesterol fed (AC) group rats, observed 
herein, was considered extremely beneficial, 
particularly in rats treated with higher dose.  
Lower levels of LDL due to Cardipro in the 
present stud suggest that this herbal product 
is a potential agent for reducing or 
controlling atherogensis and cholesterol 
deposition in peripheral tissues including 
blood vessels which is further strengthened 
by reduction in the levels of VLDL – a 
precursor of LDL. 
 
Hypertriglyceridaemia as a possible risk 
factor for development of ischaemic heart 
disease is well documented and atherogenic 
property of triglycerides is related to its 
lipoprotein transport and metabolism.  In 
hypertriglyceridaemia, these is marked 
reduction in clearance of VLDL and LDL, 
which are highly atherogenic. 
Hypertriglyceridaemia is also associated 
with hypercoagulability due to decreased 
fibrinolytic activity (12).Most 
hypercholesterolaemic drugs do not decrease 
blood triglyceride levels but cardipro 
lowered the concentration of blood 
triglyceride even in cholesterol fed rats, 
though the same was still above the healthy 
control values, in the present experiment. 
 
Accumulation of lipids and lipoprotenins is 
the most important event in the pathogenesis 
of atherosclerotic plaque formation in blood 
vessels.  In the present stud, accumulation of 
cholesterol and other lipoid materials in the 
aorta was found to be significantly less in 
cardipro treated rats as compared to 
untreated cholesterol fed rats, as evident 
from both biochemical and histological 
studies of aortic tissues.  This shows 
significant anti-atherogenic action of 
cardipro.  Arterial thrombotic occlusion, as 
seen in cholesterol fed rat aorta, complicated 
atherosclerosia causing myocardial 
infarction.  Treatment of the rats with 
cardipro did not show any presence of 
microthrombi attached to the intimal surface 
of aorta which is in accordance with 
chaturvedi who stated that T. arjuna, which 
forms as important component of cardipro. 
Possesses anticoagulant and anti-thrombotic 
activity (13). 
 
Cardipro also effectively prevented the 
deposition of calcium salts in the aortic 
tissues leading the prevention of 
atherogenesis as clacification of aortic tissue 
plays a ital role I the pathogenesis of 
atherosclerosis (14). 
 
Although the exact mechanism of action of 
cardipro can not be clearly defied at this 
stage, it is possible that E. officinalis and T 
arjuna which form important components of 
cardipro increase the fecal excretion of 
cholesterol and enhance the plasma 
lecithine-cholesterol acyl transferase 
(LCAT) activity in addition to stimulation of 
receptor medicated catabolism of LDL as 
indicated by shaila & coworkers (&) and 
mathur and coworkers (9). 
 
It has been concluded from this study that 
cardipro can be used effectively for 
amelioration of atherosclerosis and 
associated cardiac problems to a certain 
extent.  Therefore, it is recommended that 
large scale clinical trials in hyperlipidaemic 
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patients may be undertaken using cardipro, 
as it has been much higher than the 
recommended dose.
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TABLE -1: EFFECT OF CARDIPRO ON LIPID PROFILE OF EXPERIMENTALANIMALS 
 
Group Total  lipid 
(mg/dl) 
Cholesterol 
(mg/dl) 
HDL-C 
(mg/dl) 
LDL-C 
(mg/gm) 
VLDL-C  
(mg/dl) 
Trigyceride 
(mg/dl) 
Aortic 
cholesterol 
(mg/gm) 
RF# 
Control 
(HC) 
** 
193.39 ± 7.81 
** 
96.75 ± 3.72 
 
34.42 ± 
1.12 
** 
56.02 ± 
3.59 
** 
7.32 ± 
0.28 
** 
36.64 ± 
1.43 
** 
1.72 ± 
0.09 
 
2.81 
Cholesterol 
fed (AC) 
342.78 ± 7.22  185.35 ± 3.73  35.64 ±4.07  128.63  ± 
0.98 
21.08 ± 
5.05 
105.43 ± 
0.11 
3.92 ± 
5.20 
 
Cholesterol 
Fed+CardiPro 
(25mg/kg) 
(AD-50) 
* 
286.10 ± 
10.43 
* 
144.77 ± 5.06 
 
32.77 ± 
1.45 
* 
94.14 ± 
3.97 
* 
17.86 
±0.63 
* 
89.33 ± 
3.17 
* 
2.95 ± 
0.15 
 
4.41 
Cholesterol 
Fed+CardiPro 
(50mg/kg) 
(AD-50) 
** 
222.08± 9.37 
 
** 
115.60 ± 4.71 
 
35.45 ± 
1.79 
** 
67.65 ± 
4.47 
** 
12.50 ± 
0.71 
** 
62.51 ± 
3.57 
** 
2.13 ± 
0.12 
 
3.26 
 
 # RF = Risk Factor (Cholesterol/HDL –C). 
* Significant (P £ 0.05) difference with cholesterol fed (AC) rats. 
** Significant (P £ 0.01) difference with cholesterol fed (AC) rats. 
 
LEGENDS OF THE FIGURE: 
 
Fig.1 Section of aorta (AC) showing gelatinous swelling of intima, hypertrophy of medical 
muscles and presence of fat vacuoles (H&E x83). 
 
Fig.2 Section of aorta (AC) showing hypertrophy of medical coat and appearance of 
microthrombi. (H&E x83). 
 
Fig.3 Section of aorta (AC) showing rough surface of tunica intima and presence of 
vacuoles(H&E x83). 
 
Fig.4 Section of aorta (AC) showing disruption of elastic fibres and presence of discreate fat 
vaculoes (Verhoeff’s x34). 
 
Fig.5 Section of aorta (AC-50) with intact, smooth intima and absence of fat droplets  (H&E 
x83). 
 
Fig.2 Section of aorta (AC-50) with intact elastic fibres (Verhoeff’s x34).  
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